Regarding IL-10 therapy, although its administration was shown to exert cardioprotective effects in animal models (Krishnamurthy et al., 2009; Verma et al., 2012), it has not been tested yet in HF patients. This evidence concerns the gene IL10 and hydrops fetalis.